Suezanne E. Parker

6.2k total citations · 1 hit paper
40 papers, 4.8k citations indexed

About

Suezanne E. Parker is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Suezanne E. Parker has authored 40 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Immunology and 11 papers in Genetics. Recurrent topics in Suezanne E. Parker's work include Immunotherapy and Immune Responses (14 papers), RNA Interference and Gene Delivery (12 papers) and Virus-based gene therapy research (9 papers). Suezanne E. Parker is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), RNA Interference and Gene Delivery (12 papers) and Virus-based gene therapy research (9 papers). Suezanne E. Parker collaborates with scholars based in United States, Sweden and Netherlands. Suezanne E. Parker's co-authors include Gary Rhodes, Stanislaw H. Gromkowski, Varavani Dwarki, Douglas Martinez, Helen C. Perry, Philip L. Felgner, Karen Leander, Arthur Friedman, John Donnelly and Corrille M. DeWitt and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Suezanne E. Parker

40 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein

1993 1.9k citations Suezanne E. Parker, Gary Rhodes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suezanne E. Parker United States	24	2.2k	2.0k	1.2k	1.2k	952	40	4.8k
Joel R. Haynes United States	37	2.4k 1.1×	1.9k 0.9×	1.2k 0.9×	1.4k 1.2×	811 0.9×	60	4.9k
Elmars Grens Latvia	15	1.1k 0.5×	1.6k 0.8×	1.6k 1.3×	2.0k 1.7×	537 0.6×	18	5.2k
Paul Pumpens Latvia	36	1.7k 0.8×	2.2k 1.1×	2.1k 1.8×	2.9k 2.5×	695 0.7×	81	7.3k
Margaret A. Liu United States	31	4.2k 1.9×	2.8k 1.4×	2.2k 1.8×	2.5k 2.2×	1.0k 1.1×	56	7.6k
Donna L. Montgomery United States	22	1.9k 0.8×	2.1k 1.0×	1.2k 1.0×	1.3k 1.1×	604 0.6×	30	4.4k
Corrille M. DeWitt United States	14	2.0k 0.9×	1.3k 0.7×	1.2k 1.0×	1.7k 1.5×	553 0.6×	15	4.0k
Arthur Friedman United States	19	2.2k 1.0×	1.4k 0.7×	766 0.6×	1.4k 1.2×	554 0.6×	29	3.8k
Nigel J. Dimmock United Kingdom	41	1.3k 0.6×	1.4k 0.7×	1.6k 1.3×	2.6k 2.3×	709 0.7×	171	5.2k
Helen C. Perry United States	23	1.9k 0.8×	1.4k 0.7×	830 0.7×	1.7k 1.5×	649 0.7×	27	4.2k
Gary Rhodes United States	26	1.9k 0.8×	1.4k 0.7×	854 0.7×	1.1k 0.9×	643 0.7×	45	4.0k

Countries citing papers authored by Suezanne E. Parker

Since Specialization

Citations

This map shows the geographic impact of Suezanne E. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suezanne E. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suezanne E. Parker more than expected).

Fields of papers citing papers by Suezanne E. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suezanne E. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suezanne E. Parker. The network helps show where Suezanne E. Parker may publish in the future.

Co-authorship network of co-authors of Suezanne E. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Suezanne E. Parker. A scholar is included among the top collaborators of Suezanne E. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suezanne E. Parker. Suezanne E. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García, Daniel, Alice Pierre, Vasudevan Ayyappan, et al.. (2024). Lipid nanoparticle delivery of TALEN mRNA targeting LPA causes gene disruption and plasma lipoprotein(a) reduction in transgenic mice. Molecular Therapy. 33(1). 90–103. 2 indexed citations

Wang, Hong, et al.. (2020). Genotoxicity and carcinogenicity risk assessment of prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist. Regulatory Toxicology and Pharmacology. 112. 104586–104586. 3 indexed citations

Wehner, Nancy, George M. Shopp, J. Arly Nelson, et al.. (2009). Immunotoxicity profile of natalizumab. Journal of Immunotoxicology. 6(2). 115–129. 16 indexed citations

Singh, Gita, Suezanne E. Parker, & Peter Hobart. (2002). The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma. Vaccine. 20(9-10). 1400–1411. 11 indexed citations

Fleeton, Marina N., Margaret Chen, Peter Berglund, et al.. (2001). Self‐Replicative RNA Vaccines Elicit Protection against Influenza A Virus, Respiratory Syncytial Virus, and a Tickborne Encephalitis Virus. The Journal of Infectious Diseases. 183(9). 1395–1398. 125 indexed citations

Le, Thong P., Kevin Coonan, Richard C. Hedstrom, et al.. (2000). Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine. 18(18). 1893–1901. 174 indexed citations

Clark, Paul, Alison Stopeck, Suezanne E. Parker, & Evan M. Hersh. (2000). Cationic Lipid Gene Transfer of an IL-2 Transgene Leads to Activation of Natural Killer Cells in a SCID Mouse Human Tumor Xenograft. Cellular Immunology. 204(2). 96–104. 7 indexed citations

Clark, Paul, Alison Stopeck, Marilyn E. Ferrari, Suezanne E. Parker, & Evan M. Hersh. (2000). Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA. Cancer Gene Therapy. 7(6). 853–860. 24 indexed citations

Horton, Holly M., et al.. (1999). IL-2 Plasmid Therapy of Murine Ovarian Carcinoma Inhibits the Growth of Tumor Ascites and Alters Its Cytokine Profile. The Journal of Immunology. 163(12). 6378–6385. 23 indexed citations

10.

Parker, Suezanne E., Flavia Borellini, Martin L. Wenk, et al.. (1999). Plasmid DNA Malaria Vaccine: Tissue Distribution and Safety Studies in Mice and Rabbits. Human Gene Therapy. 10(5). 741–758. 82 indexed citations

11.

Parker, Suezanne E., et al.. (1997). Tissue Distribution of the Cytofectin Component of a Plasmid–DNA/Cationic Lipid Complex Following Intravenous Administration in Mice. Human Gene Therapy. 8(4). 393–401. 18 indexed citations

12.

Hostetler, Karl Y., Douglas D. Richman, Eric A. Forssen, et al.. (1994). Phospholipid prodrug inhibitors of the HIV protease. Biochemical Pharmacology. 48(7). 1399–1404. 9 indexed citations

13.

Zhou, Xianzheng, Peter Berglund, Gary Rhodes, et al.. (1994). Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine. 12(16). 1510–1514. 155 indexed citations

14.

Yankauckas, Michelle A., Jane Morrow, Suezanne E. Parker, et al.. (1993). Long-Term Anti-Nucleoprotein Cellular and Humoral Immunity Is Induced by Intramuscular Injection of Plasmid DNA Containing NP Gene. DNA and Cell Biology. 12(9). 771–776. 127 indexed citations

15.

Fazakerley, John K., Suezanne E. Parker, Floyd E. Bloom, & Michael J. Buchmeier. (1992). The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 187(1). 178–188. 92 indexed citations

16.

North, Richard B., Benjamin Drenger, Charles Beattie, et al.. (1991). Monitoring of spinal cord stimulation evoked potentials during thoracoabdominal aneurysm surgery. Neurosurgery. 325–325. 2 indexed citations

17.

Parker, Suezanne E. & Duane W. Sears. (1990). H-2 Restriction and Serotype Crossreactivity of Anti-Reovirus Cytotoxic T Lymphocytes (CTL). Viral Immunology. 3(1). 77–87. 5 indexed citations

18.

Parker, Suezanne E. & Michael J. Buchmeier. (1990). RNA Sequence Analysis of the E2 Genes of Wildtype and Neuroattenuated Mutants of MHV-4 Reveals a Hypervariable Domain. Advances in experimental medicine and biology. 276. 395–402. 1 indexed citations

19.

Parker, Suezanne E., et al.. (1989). Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology. 173(2). 664–673. 131 indexed citations

20.

Parker, Suezanne E., Ying Sun, & Duane W. Sears. (1988). DIFFERENTIAL EXPRESSION OF THE ASGM₁ ANTIGEN ON ANTI‐REOVIRUS AND ALLOREACTIVE CYTOTOXIC T LYMPHOCYTES (CTL). International Journal of Immunogenetics. 15(4). 215–226. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact